Back to top
more

Neogen (NEOG)

(Delayed Data from NSDQ)

$14.44 USD

14.44
1,190,769

+0.16 (1.12%)

Updated Nov 1, 2024 04:00 PM ET

After-Market: $14.45 +0.01 (0.07%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

4-Sell of 5       4  

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value F Growth F Momentum F VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 30% (74 out of 250)

Industry: Medical - Products

Better trading starts here.

Zacks News

Neogen Q1 Earnings Miss Estimates, Margins Crash

NEOG's Food Safety and Animal Safety businesses witness a year-over-year decrease in revenues in the first quarter of fiscal 2025.

Company News for Oct 11, 2024

Companies in The News Are: DAL,DPZ,NEOG,TXG

Compared to Estimates, Neogen (NEOG) Q1 Earnings: A Look at Key Metrics

Although the revenue and EPS for Neogen (NEOG) give a sense of how its business performed in the quarter ended August 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Neogen (NEOG) Misses Q1 Earnings Estimates

Neogen (NEOG) delivered earnings and revenue surprises of -30% and 0.39%, respectively, for the quarter ended August 2024. Do the numbers hold clues to what lies ahead for the stock?

Insights Into Neogen (NEOG) Q1: Wall Street Projections for Key Metrics

Evaluate the expected performance of Neogen (NEOG) for the quarter ended August 2024, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.

ImmunoPrecise Antibodies Ltd. (IPA) Reports Q1 Loss, Misses Revenue Estimates

ImmunoPrecise Antibodies (IPA) delivered earnings and revenue surprises of -22.22% and 22.44%, respectively, for the quarter ended July 2024. Do the numbers hold clues to what lies ahead for the stock?

Is the Options Market Predicting a Spike in Neogen (NEOG) Stock?

Investors need to pay close attention to Neogen (NEOG) stock based on the movements in the options market lately.

InnovAge Holding Corp. (INNV) Reports Q4 Loss, Tops Revenue Estimates

InnovAge (INNV) delivered earnings and revenue surprises of 50% and 4.85%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?

Neogen (NEOG) Down 1.2% Since Last Earnings Report: Can It Rebound?

Neogen (NEOG) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Neogen Suffers From Competitive Pressure, Macroeconomic Woes

NEOG faces intense competition, which could affect the marketability and profitability of its products.

Is the Options Market Predicting a Spike in Neogen (NEOG) Stock?

Investors need to pay close attention to Neogen (NEOG) stock based on the movements in the options market lately.

Neogen (NEOG) Q4 Earnings Miss Estimates, Margins Crash

Neogen's (NEOG) Food Safety and Animal Safety businesses witness a year-over-year decrease in revenues in the fourth quarter of fiscal 2024.

Neogen (NEOG) Lags Q4 Earnings Estimates

Neogen (NEOG) delivered earnings and revenue surprises of -16.67% and 5.14%, respectively, for the quarter ended May 2024. Do the numbers hold clues to what lies ahead for the stock?

Here's Why Staying Invested in Neogen (NEOG) Could be Beneficial

Neogen (NEOG) instills optimism among investors with its strategic progress and a string of product launches.

Neogen (NEOG) Expands in Food Safety With Petrifilm Feeder Launch

Neogen (NEOG) launches Petrifilm Automated Feeder, which allows automatic feeding and enumeration of up to 300 petrifilm plates in 33 minutes. The system improves the efficiency of food safety testing labs.

Do Options Traders Know Something About Neogen (NEOG) Stock We Don't?

Investors need to pay close attention to Neogen (NEOG) stock based on the movements in the options market lately.

Neogen's (NEOG) MDS Secures New Contract From USDA FSIS

Neogen's (NEOG) MDS gets recognized by the USDA FSIS as the primary method for the detection of Salmonella and Listeria monocytogenes testing for meat, poultry and egg products.

Abbott (ABT) Down 0.4% Since Last Earnings Report: Can It Rebound?

Abbott (ABT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Do Options Traders Know Something About Neogen (NEOG) Stock We Don't?

Investors need to pay close attention to Neogen (NEOG) stock based on the movements in the options market lately.

Neogen (NEOG) Faces Macroeconomic Issues, Fierce Competition

Neogen (NEOG) faces intense competition from companies ranging from small businesses to divisions of large multinational companies.

Neogen (NEOG) Down 3.6% Since Last Earnings Report: Can It Rebound?

Neogen (NEOG) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Neogen (NEOG) Inks Genomics Deal to Aid in Food Tracing

Neogen (NEOG) announces a genomics relationship with Performance Food Group to trace food products back to their origin using PathProven food trace technology.

Company News for Apr 10, 2024

Companies in The News Are: MRNA, MRK, COIN, BN, NEOG

Neogen (NEOG) Q3 Earnings Miss Estimates, Gross Margin Expands

Neogen's (NEOG) third-quarter fiscal 2024 results reflect solid core revenue growth in both segments.

Here's What Key Metrics Tell Us About Neogen (NEOG) Q3 Earnings

While the top- and bottom-line numbers for Neogen (NEOG) give a sense of how the business performed in the quarter ended February 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.